Andrew Chu, MD
- Gastroenterology, Hepatology and Nutrition
Attending Physician, Division of Gastroenterology, Hepatology & Nutrition
Associate Professor of Pediatrics, Baylor College of Medicine
Faculty Senator, School of Medicine
Clinical Lead, Multidisciplinary Abdominal Pain Program
Phone:
936-267-7555
Fax:
936-267-7922
Languages: English
Get to know Andrew Chu, MD
Dr. Chu serves as attending physician in Pediatric Gastroenterology at Texas Children’s Hospital and is associate professor of Pediatrics at Baylor College of Medicine. He believes that building strong partnerships with families and other care providers is key to fully leveraging the resources of our health system for the care of children. He provides general gastroenterology care at Texas Children's Hospital The Woodlands. His clinical and research interests focus on the evaluation and management of children with disorders of gut-brain interaction (DGBIs, also known as functional abdominal disorders). This served as his motivation to co-found and serve as clinical lead for the Multidisciplinary Abdominal Pain Program (MAPP) at Texas Children’s Hospital. This is a collaborative initiative involving Gastroenterology, Anesthesiology, Psychology, Nutrition and Physical Therapy that provides quaternary consultative services for children suffering from DGBIs. He also serves as clinical lead for the Multidisciplinary Feeding Clinic at The Woodlands campus, a collaborative initiative involving Gastroenterology, Speech Language Pathology, Occupational Therapy, and Nutrition to provide outpatient evaluation and management of children with chronic feeding difficulties.
Dr. Chu has been recognized by Baylor College of Medicine and Texas Children's Hospital with some of their highest clinical recognitions for his exceptional clinical care, including the Department of Pediatrics Chair's Outstanding Clinician Award and the Ambulatory Practitioner Award for Excellence in Patient Experience.
Clinical Interests
Dr. Chu cares for the full range of issues in general pediatric gastroenterology and hepatology. He has clinical and research interest in the management of functional abdominal pain and is involved in the Neurogastroenterology program.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Children's Hospital of Philadelphia | Research Fellowship | Research | 2011 |
| Children's Hospital of Philadelphia | Fellowship | Pediatric Gastroenterology | 2010 |
| Cincinnati Children's Hospital Medical Center | Residency | Pediatrics | 2007 |
| Baylor College of Medicine | Medical School | Doctor of Medicine | 2004 |
Organizations
| Organization Name | Role |
|---|---|
| North American Society for Pediatric Gastroenterology, Hepatology & Nutrition | Member |
| American Gastroenterological Association | Member |
| American Association of Pediatrics | Fellow |
Awards
Baylor College of Medicine Department of Pediatrics Chair's Outstanding Clinician Award
Texas Children’s Hospital Ambulatory Practitioner Award for Excellence in Patient Experience (2022, 2023)
Houstonia Magazine Top Doctors (2020, 2021, 2022, 2023)
Baylor College of Medicine Early Career Faculty Award for Excellence in Patient Care (2019)
Texas Children’s Hospital The Woodlands Shining Star Award (2018)
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Reviews
Rudnick DA, Huang J, Hidvegi T, Chu AS, Hale P, Munanairi A, Dietzen DJ, Cliften PF, Tycksen E, Lutkewitte AJ, Finck BN, Pak SC, Silverman GA, Perlmutter DH. Regulation of PGC1a Downstream of the Insulin Signaling Pathway Plays a Role in the Hepatic Proteotoxicity of Mutant a1-Antitrypsin Deficiency Variant Z. Gastroenterology. 2022 Mar 15. PMID: 35301011.
Chu AS, Torres L, Kao G, Gilbert C, Monico EC, Chumpitazi BP. Multidisciplinary Care for Refractory Pediatric Functional Abdominal Pain Decreases Emergency and Inpatient Utilization. J Pediatric Gastroenterology and Nutrition. 2022;74:248-52. PMID: 34560729.
Moffett BS, Schmees L, Zinser K, Erikson C, Chu A, Strobel N. Evaluation of intravenous ranitidine for gastric acid suppression in critically ill pediatric patients. The Journal of Pediatric Pharmacology and Therapeutics. 2019;24:504-509. PMID: 31719812.
Wang Y, Cobanoglu MC, Li J, Hidvegi T, Hale P, Ewing M, Chu AS, Gong Z, Muzumdar R, Pak SC, Silverman GA, Bahar I, Perlmutter DH. An analog of glibenclamide selectively enhances autophagic degradation of misfolded a1-antitrypsin Z. PLoS One. 2019; 14(1):e0209748. PMID: 30673724.
Chu A, Chopra KB, Perlmutter DH. Is severe progressive liver disease caused by alpha1-antitrypsin deficiency more common in children or adults? Liver Transplantation. 2016;22:886-94. PMID: 26946192.
Perlmutter D, Chopra K, Chu A. Two new considerations for improving the diagnosis of α-1-antitrypsin deficiency-associated liver disease. Digestive Diseases and Sciences. 2015;60:1511-13. PMID:25634676.
Chu A, Perlmutter DH, Wang Y. Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases. BioMed Research International. 2014;2014:1-8. PMID: 25025052.
Chu A, Russo PA, Wells RG. Cholangiocyte cilia are abnormal in syndromic and non-syndromic biliary atresia. Modern Pathology. 2011;25:751-7. PMID: 22301700.
Chu A, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, Stanger BZ, Wells RG. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology. 2011; 53:1685-95. PMID: 21520179.
